Intelligent Bio Solutions (NASDAQ:INBS) Trading 4.5% Higher

Shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS) traded up 4.5% on Thursday . The company traded as high as $3.28 and last traded at $2.80. 162,360 shares were traded during trading, a decline of 94% from the average session volume of 2,738,967 shares. The stock had previously closed at $2.68.

Intelligent Bio Solutions Price Performance

The firm has a market cap of $7.96 million, a PE ratio of -0.03 and a beta of 4.82. The stock has a 50 day moving average price of $4.32 and a two-hundred day moving average price of $3.97. The company has a quick ratio of 0.39, a current ratio of 0.57 and a debt-to-equity ratio of 0.07.

Intelligent Bio Solutions (NASDAQ:INBS) last announced its earnings results on Friday, February 9th. The company reported ($2.07) earnings per share for the quarter, topping the consensus estimate of ($3.24) by $1.17. The business had revenue of $0.76 million during the quarter. Intelligent Bio Solutions had a negative return on equity of 266.16% and a negative net margin of 544.63%. As a group, equities analysts expect that Intelligent Bio Solutions Inc. will post -3.67 earnings per share for the current year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Intelligent Bio Solutions stock. Citadel Advisors LLC purchased a new position in shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 156,390 shares of the company’s stock, valued at approximately $53,000. Citadel Advisors LLC owned approximately 21.48% of Intelligent Bio Solutions as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 32.97% of the company’s stock.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.